Cargando…
Tissue Profile of CDK4 and STAT3 as Possible Innovative Therapeutic Targets in Urinary Bladder Cancer
Bladder cancer represents a global health problem. It ranks ninth in worldwide cancer incidence. In Egypt, carcinoma of the bladder is the most prevalent cancer, Bladder cancer has the highest recurrence rate of any malignancy. Certainly, suitable molecular diagnostic markers are required to improve...
Autores principales: | Aboushousha, Tarek, Hammam, Olfat, Aref, Ahmed, Kamel, Amira, Badawy, Mohamed, Hamid, Amr Abdel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332140/ https://www.ncbi.nlm.nih.gov/pubmed/32102537 http://dx.doi.org/10.31557/APJCP.2020.21.2.547 |
Ejemplares similares
-
Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis
por: Hammam, Olfat, et al.
Publicado: (2017) -
Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis
por: Aboushousha, Tarek, et al.
Publicado: (2018) -
Molecular Detection of Genetic Susceptibility to Bladder Cancer in Egyptian Patients
por: Mamdouh, Samah, et al.
Publicado: (2022) -
Detection of Epithelial-Mesenchymal Transition Markers in High Grade Bladder Cancer and Special Variants of Urothelial Carcinoma
por: Khalil, Heba, et al.
Publicado: (2022) -
Overview of MDM2 and B-RAF Expression in Gastric Lesions
por: Aboushousha, Tarek, et al.
Publicado: (2018)